Due to Easter holiday, all delivery service requests will not be processed on Friday, April 10, 2020. Regular delivery schedule will resume on Monday, April 13, 2019.
PEAK1, Unactive(P18-14G)

PEAK1, Unactive(P18-14G)

  • $215.00


FOR BULK ORDER REQUESTS PLEASE CONTACT US

Description :Recombinant human PEAK1 (1127-end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.

Species :Human

Tag :GST tag

Expression System:Sf9 insect cells using baculovirus

Sequence :1127-end

Genbank Number :NM_024776

Purity :Sample Purity Data. For specific information on a given lot, see related technical data sheet.

Storage, Stability and Shipping :Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.

Applications :Kinase Assay, Western Blot

Molecular Weight :~100 kDa

Gene Aliases :SGK269

Scientific Background :PEAK1 or Pseudopodium-enriched atypical kinase 1 is a protein tyrosine kinase which belongs to NKF3 kinase family and regulates the cytoskeleton and has been shown to be involved in cancer progression (1). PEAK1 promotes anchorage-independent growth in the MDA-MB-435 human cancer cell line and promotes tumor progression of XPA-1 human pancreatic cancer cells when transplanted into the pancreas of nude mice. PEAK1 is highly expressed in spleen, followed by heart, ovary, brain, lung, kidney, and fetal brain (2).

References :
1. Wang, Y. et.al: Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression. Proc. Nat. Acad. Sci. 107: 10920-10925, 2010.

2. Ohara, O. et.al: Characterization of size-fractionated cDNA libraries generated by the in vitro recombination-assisted method. DNA Res. 9: 47-57, 2002.

Product Sheets (By Lot #) :

F576-3.pdf

Research Areas :Cancer, Cytoplasmic Tyrosine Kinases, ERK/MAPK Pathway, Cancer, ERK/MAPK Pathway, Cytoplasmic Tyrosine Kinases